After Win, FDA May Backtrack On More Device Approvals
Law360, New York (April 29, 2013, 9:30 PM EDT) -- Earlier this month, a federal judge backed the U.S. Food and Drug Administration's decision to revoke its marketing clearance for a knee implant more than two years after it had initially granted it, a ruling that attorneys worry may embolden the agency to make similar retractions on other medical devices.
U.S. District Judge Robert Wilkins granted the FDA summary judgment April 10 in a suit brought by ReGen Biologics Inc., after the agency decided to rescind its clearance of ReGen's Menaflex knee implant.
The FDA had cleared the implant for marketing in December 2008, but after the change in administrations, the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!